Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Targeted protein degradation

You can glue it too!

Nature Chemical Biology volume 13, pages 452–453 (2017)Cite this article

Subjects

Proteolysis-targeting chimera (PROTACs) are synthetic molecules that recruit neo-substrate proteins to a ubiquitin ligase for ubiquitination and subsequent degradation. Structural insight into the VHL–MZ1–BRD4 complex reveals how the rationally designed MZ1–PROTAC molecule mediates degradation of an unnatural protein substrate.

The physiological role of the majority of E3 ubiquitin ligases is to ubiquitinate native substrate proteins, targeting them for proteolysis by the 26S proteasome. The cullin–RING ligase (CRL) family comprises over 230 different CRLs that recognize hundreds of substrates throughout diverse cellular pathways8. Substrate recruitment depends on short peptide sequences, called destruction motifs, or degrons, and is regulated by post-translational modifications, protein cofactors, or low-molecular-weight compounds. Fusion of degrons to unrelated proteins results in degradation, illustrating that ubiquitination is highly promiscuous and restrained mostly by spatial proximity to the ligase9. Thalidomide, clinically used in the treatment of multiple myeloma, emerged as the first synthetic small molecule that takes advantage of an E3 ligase10. Thalidomide repurposes the CRL4CRBN (cereblon) ubiquitin ligase by acting as molecular glue that mounts disease-related proteins onto the E3 ligase9. The glue-induced protein–protein interactions substantially contribute to target specificity (Fig. 1b). The coincidental discovery of thalidomide's mode of action provided precedence for a novel class of drugs and revived efforts to artificially induce degradation of key therapeutic targets by synthetic molecules.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Mechanism of neo-substrate degradation by bifunctional degraders.

References

  1. Kenten, J.H. & Roberts, S.F. Controlling protein levels in eucaryotic organisms. US patent 6306663 B1 (2001).

  2. Winter, G.E. et al. Science 348, 1376–1381 (2015).

    Article  CAS  Google Scholar 

  3. Lu, J. et al. Chem. Biol. 22, 755–763 (2015).

    Article  CAS  Google Scholar 

  4. Zengerle, M., Chan, K.H. & Ciulli, A. ACS Chem. Biol. 10, 1770–1777 (2015).

    Article  CAS  Google Scholar 

  5. Sakamoto, K.M. et al. Proc. Natl. Acad. Sci. USA 98, 8554–8559 (2001).

    Article  CAS  Google Scholar 

  6. Fischer, E.S., Park, E., Eck, M.J. & Thomä, N.H. Curr. Opin. Struct. Biol. 37, 115–122 (2016).

    Article  CAS  Google Scholar 

  7. Gadd, M.S. et al. Nat. Chem. Biol. 13, 514–521 (2017).

    Article  CAS  Google Scholar 

  8. Deshaies, R.J. & Joazeiro, C.A. Annu. Rev. Biochem. 78, 399–434 (2009).

    Article  CAS  Google Scholar 

  9. Petzold, G., Fischer, E.S. & Thomä, N.H. Nature 532, 127–130 (2016).

    Article  CAS  Google Scholar 

  10. Ito, T. & Handa, H. Int. J. Hematol. 104, 293–299 (2016).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Michal J. Walczak, Georg Petzold and Nicolas H. Thomä are at the Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.,

    Michal J Walczak, Georg Petzold & Nicolas H Thomä

Authors
  1. Michal J Walczak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Georg Petzold
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicolas H Thomä
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolas H Thomä.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Walczak, M., Petzold, G. & Thomä, N. You can glue it too!. Nat Chem Biol 13, 452–453 (2017). https://doi.org/10.1038/nchembio.2355

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nchembio.2355

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing